Pharmacology

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Dr. Omar Tupayachi - 5 June, 2026 0

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 4 June, 2026 0

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Dr. Juan Manuel Pérez - 3 June, 2026 0

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

Institutional News

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

solaci - 4 June, 2026 0

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

solaci - 2 June, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

solaci - 1 June, 2026 0

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

Many Guidelines, Much Confusion. Blood Pressure Targets in the Elderly

After Much Toing and Froing, Gastrointestinal Protection Is Back to the Forefront

Antithrombotic Strategies in Atrial Fibrillation and Angioplasty

Aspirin in Primary Prevention: Another “Trendy” Topic in Publications

Cardiovascular Risk, Dual Antiplatelet Therapy, and Age. What Should We Know?

EuroPCR 2019 | Global Leaders: Ticagrelor Monotherapy at Long Term Could Have a Role in Complex PCI

Bariatric Surgery Associated with a Lower Rate of Mortality Due to Infarction and Stroke

The First Antidote Against Ticagrelor Is a Rapid-Acting, Extended Effect Agent in Preliminary Results